medigraphic.com
ISSN 2954-3835 (Digital)
ISSN 2683-2828 (Impreso)

2020, Número S3

<< Anterior Siguiente >>

Cardiovasc Metab Sci 2020; 31 (S3)


Extractos de los documentos de posicionamientos y recomendaciones mexicanas en enfermedades cardiovasculares y COVID-19

Gutiérrez-Fajardo P, Alcocer-Gamba MA, Cabrera-Rayo A, Sosa-Caballero A, Piña-Reyna Y, Merino-Rajme JA, Heredia-Delgado JA, Cruz-Alvarado JE, Galindo-Uribe J, Rogel-Martínez U, González-Hermosillo JA, Ávila-Vanzzini N, Sánchez-Carranza JA, Jiménez-Orozco JH, Sahagún-Sánchez G, Fanghänel-Salmón G, Albores-Figueroa R, Carrillo-Esper R, Reyes-Terán G, Cossio-Aranda JE, Borrayo-Sánchez G, Odín-De los Ríos M, Berni-Betancourt AC, Cortés-Lawrenz J, Leiva-Pons JL, Ortiz-Fernández PH, López-Cuellar J, Araiza-Garaygordobil D, Madrid-Miller A, Saturno-Chiu G, Beltrán-Nevárez O, Enciso-Muñoz JM, García-Rincón A, Pérez-Soriano P, Herrera-Gomar M, Lozoya RJJ, Fajardo-Juárez AI, Olmos-Temois SG, Rodríguez-Reyes H, Ortiz-Galván F, Márquez-Murillo MF, Celaya-Cota MJ, Cigarroa-López JA, Magaña-Serrano JA, Álvarez-Sangabriel A, Ruíz-Ruíz V, Chávez-Mendoza A, Méndez-Ortíz A, León-González S, Guízar-Sánchez C, Izaguirre-Ávila R, Grimaldo-Gómez FA, Preciado-Anaya A, Ruiz-Gastélum E, Fernández-Barros CL, Gordillo A, Alonso-Sánchez J, Cerón-Enríquez N, Núñez-Urquiza JP, Silva-Torres J, Pacheco-Beltrán N, García-Saldivia MA, Pérez-Gámez JC, Lezama-Urtecho C, López-Uribe C, López-Mora GE, Rivera-Reyes R

Idioma: Inglés [English version]
Referencias bibliográficas: 45
Paginas: 271-283
Archivo PDF: 255.51 Kb.


RESUMEN

Se presentan las recomendaciones en las cuales, la Sociedad Mexicana de Cardiología (SMC) en conjunto con la Asociación Nacional de Cardiólogos de México (ANCAM), así como diferentes asociaciones médicas mexicanas vinculadas con la cardiología, después de una revisión y análisis exhaustivo y consensuado sobre los tópicos relacionados con las enfermedades cardiovasculares en la pandemia de COVID-19, se analizan posturas científicas y se dan recomendaciones responsables sobre medidas generales a los pacientes, con cuidados personales, alimentación saludable, actividad física regular, acciones en caso de paro cardiorrespiratorio, la protección del paciente y del personal de salud, así como las indicaciones precisas en el uso de la imagen cardiovascular no invasiva, la prescripción de medicamentos, cuidados en tópicos específicos como en la hipertensión arterial sistémica, insuficiencia cardiaca, arritmias y síndromes coronarios agudos, además de hacer énfasis en los procedimientos de electrofisiología, intervencionismo, cirugía cardiaca y en la rehabilitación cardiaca. El interés principal es brindar a la comunidad médica una orientación general sobre el quehacer en la práctica cotidiana y pacientes con enfermedades cardiovasculares en el escenario de esta crisis epidemiológica sin precedentes de COVID-19.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Davies A, Thompson KA, Giri K, Kafatos G, Walker J, Bennett A. Testing the efficacy of homemade masks: Would they protect in an influenza pandemic? Disaster Med Public Health Prep. 2013; 7 (4): 413-418.

  2. Brienen CJ, Timen A, Wallinga J, van Steenbergen JE, Teunis P. The effect of mask use on the spread of influenza during a pandemic. Risk Anal. 2010; 30 (8): 1210-1218.

  3. Van der Sande M, Teunis P, Sabel R. Professional and home-made fase masks reduce exposure to respiratory infections among the general population. PLoS One. 2008; 3 (7): e2618.

  4. MacIntyre CR, Cauchemez S, Dayer DE, Seale H, Cheung P, Browne G et al. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis. 2009; 15 (2): 233-241.

  5. Interim Guidance for Healthcare Providers during COVID-19. Outbreak [Internet]. EE.UU.: American Heart Association, U.S. Centers for Disease Control, World Health Organization; 11/03/2020. Disponible en: https://professional.heart.org/idc/groups/ahamahpublic/@ wcm/@sop/@smd/documents/downloadable/ ucm_505872.pdf

  6. Anesthesia Patient Safety Foundation and World Federation of Societies of Anesthesiologist.

  7. COVID-19 Clinical Guidance for the Cardiovascular Care Team [Internet]. EE.UU.: American College of Cardiology; 6 de marzo de 2020. Disponible en: https://www.acc.org//~/media/Non-Clinical/Files- PDFs-Excel-MS- Word-etc/2020/02/S20028-ACCClinical- Bulletin-Coronavirus.pdf

  8. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 Feb 7. doi: 10.1001/ jama.2020.1585. [Epub ahead of print]

  9. García Fernández MA, Cabrera Schulmeyer MC, Azcárate Agüero PM. Documento sobre el uso de la ecocardiografía en pacientes con COVID-19 [Internet]. Sociedad Española de Imagen Cardiaca; 17/03/2020. Disponible en: https://ecocardio.com/docs/UsoEcocardiografiaCOVID19. pdf

  10. Cook TM, El-Boghdadly K, McGuire B, McNarry F, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Association of Anaesthetists, the Difficult Airway Society, the intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists. Anaesthesia. 2020; 75 (6): 785-799.

  11. Kirkpatrick JN, Mitchell C, Taub C, Kort S, Hung J, Swaminathan M. ASE Statement on protection of patients and echocardiography service providers During the 2019 Novel Coronavirus Outbreak. J Am Coll Cardiol. 2020 Apr 6. doi: 10.1016/j.jacc.2020.04.002. [Epub ahead of print]

  12. Choi AD, Abbara S, Branch KR, Feuchtner GM, Ghoshhajra B, Nieman K et al. Society of Cardiovascular Computed Tomography guidance for use of cardiac computed tomography amidst the COVID-19 pandemic Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr. 2020 Mar 21. doi: 10.1016/j.jcct.2020.03.002. [Epub ahead of print]

  13. Kooraki S, Hosseiny M, Myers L, Gholamrezanezhad A. Coronavirus (COVID-19) outbreak: what the Department of Radiology should know. J Am Coll Radiol. 2020; 17: 447-451.

  14. Revel MP, Parkar AP, Prosch H, Silva M, Sverzelatti N, Gleeson F et al.; on behalf of the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). COVID-19 patients and the Radiology department — advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). Eur Radiol. 2020 Apr 20. doi: 10.1007/ s00330-020-06865-y. [Epub ahead of print]

  15. Skali H, Murthy VL, Al-Mallah MH, Bateman TM, Beanlands R, Better N et al. Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI [published online ahead of print, 2020 May 15]. J Nucl Med. 2020. Disponible en: https://zenodo. org/ record/3738020#.XoX62XIpBhF

  16. SCMR’s COVID-19 preparedness toolkit [Internet]. Society for Cardiovascular Magnetic Resonance; 25 de marzo de 2020. Disponible en: https://scmr.org/page/COVID19

  17. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW et al. Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020; 75 (18): 2372-2375.

  18. Speciality guides for patient management during the coronavirus pandemic. Clinical guide for the management of cardiology patients during the coronavirus pandemic [Internet]. Reino Unido: NHS; 20/03/2020. Disponible en: https://www.england.nhs.uk/coronavirus/ wp-content/uploads/si- tes/52/2020/03/specialtyguide- cardiolgy-coronavirus-v1-20-march.pdf

  19. Yang S, Manjunath L, Willemink MJ, Nieman K. The role of coronary CT angiography for acute chest pain in the era of high-sensitivity troponins. J Cardiovasc Comput Tomogr. 2019; 13 (5): 267-273.

  20. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli- Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Rev Esp Cardiol (Engl Ed). 2017; 70 (12): 1082.

  21. Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital. Intensive Care Med. 2020 Mar 11. doi: 10.1007/s00134-020-05993- 9. [Epub ahead of print]

  22. Romaguera R, Cruz-González I, Jurado-Román A, Ojeda S, Fernández-Cisnal A, Jorge-Pérez P et al. Consideraciones sobre el abordaje invasivo de la cardiopatía isquémica y estructural durante el brote de coronavirus COVID-19. Documento de consenso de la Asociación de Cardiología Intervencionista y la Asociación de Cardiopatía Isquémica de la Sociedad Española de Cardiología. REC Interv Cardiol. 2020; 2: 112-117.

  23. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology(ESC). Eur Heart J. 2016; 37 (3): 267-315.

  24. Mahmud E. The evolving pandemic of COVID-19 and interventional cardiology. Catheter Cardiovasc Interv. 2020 Apr 12. doi: 10.1002/ccd.28894. [Epub ahead of print]

  25. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361 (9351): 13-20.

  26. Drake D, Morrow CD, Kinlaw K, De Bonis M, Zangrillo A, Sade RM; Cardiothoracic Ethics Forum. Cardiothoracic surgeons in pandemics: ethical considerations. Ann Thorac Surg. 2020 Apr 9. doi: 10.1016/j. athoracsur. 2020.03.006. [Epub ahead of print]

  27. Ti LK, Ang LS, Foong TW, Ng BSW. What we do when a COVID-19 patient needs an operation: operating room preparation and guidance. Can J Anaesth. 2020 Mar 6. doi: 10.1007/s12630-020-01617-4. [Epub ahead of print]

  28. Lauer SA, Grantz KH, Bi Q et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020; 172 (9): 577-582.

  29. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507-513.

  30. Implicaciones de la pandemia por COVID-19 para el paciente con insuficiencia cardiaca, trasplante cardiaco y asistencia ventricular. Recomendaciones de la Asociación de Insuficiencia Cardiaca de la Sociedad Española de Cardiología [Internet]. Sociedad Española de Cardiología, Asociación de Insuficiencia Cardiaca; 2020. Disponible en: https://secardiologia.es/images/ secciones/insuficiencia/Implicaciones_de_la_pandemia_ por_COVID-19_para_el_paciente_con_insuficiencia_ cardiaca_trasplante_cardiaco_y_asistencia_ ventricular.pdf

  31. Recomendaciones al Subsistema Nacional de Donación y Trasplantes sobre la infección asociada al SARS-CoV-2 (COVID-19) [Internet]. México: Centro Nacional de Trasplantes; 1 de abril de 2020. Disponible en: https://www.gob.mx/cenatra/articulos/ recomendaciones-al-subsistema-nacional-de-donacion- y-trasplantes-sobre-la-infeccion-asociada-al-sarscov- 2-covid-19-238147

  32. Torres A, Rivera A, García A, Arias C, Saldarriaga C, Gómez E et al. Evaluación y tratamiento de la insuficiencia cardiaca durante la pandemia de COVID-19: resumen ejecutivo [Internet]. Sociedad Colombiana de Cardiología & Cirugía Cardiovascular, Revista Colombiana de Cardiología; abril de 2020. Disponible en: http://revcolcard.org/evaluacion-y-tra- tamientode- la-insuficiencia-cardiaca-durante-la-pandemia-deco- vid-19-resumen-ejecutivo/

  33. Guidance from the CCS COVID-19 rapid response team and CCS affiliate organizations [Internet]. Canadian Cardiovascular Society; 2020. Disponible en: https://www.ccs.ca/en/

  34. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016; 37 (1): 67-119.

  35. Benza RL, Gomberg-Maitland M, Elliott CG, Farber HW, Foreman AJ, Frost AE et al. Predicting survival in patients with pulmonary arterial hypertension: the REVEAL Risk Score Calculator 2.0 and comparison with ESC/ERS-based risk assessment strategies. Chest. 2019; 156 (2): 323-337.

  36. Humbert M, Sitbon O, Yaici A, Montani D, O’Callaghan DS, Jais X et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J. 2010; 36 (3): 549-555.

  37. Pandolfi R, Barreira B, Moreno E, Lara-Acedo V, Morales-Cano D, Martínez-Ramas A et al. Role of acid sphingomyelinase and IL-6 as mediators of endotoxininduced pulmonary vascular dysfunction. Thorax. 2017; 72 (5): 460-471.

  38. Pan IZ, Carey JR, Jacobs JA, Dechand J, Sessions JJ, Sorensen T et al. Transitioning between prostanoid therapies in pulmonary arterial hypertension. Front Med (Lausanne). 2020; 7: 81.

  39. Hoeper MM, Benza RL, Corris P, de Perrot M, Fadel E, Keogh AM et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J. 2019; 53 (1): 1801906.

  40. https://www.who.int/publications-detail/clinical-management- of-severe-acute-respiratory-infection-whennovel- coronavirus-(ncov)-infection-is-suspected)

  41. Padang R, Chandrashekar N, Indrabhinduwat M, Scott CG, Luis SA, Chandrasekaran K et al. Aetiology and outcomes of severe right ventricular dysfunction. Eur Heart J. 2020; 41 (12): 1273-1282.

  42. Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D et al. Outcomes of hospitalization for right heart failure in pulmonary arterial hypertension. Eur Respir J. 2011; 38 (2): 359-367.

  43. Wang D, Li S, Jiang J, Yan J, Zhao C, Wang Y et al. Section of precision medicine group of Chinese Society of Cardiology, editorial board of Chinese Journal of Cardiology, Working Group of Adult Fulminant Myocarditis. Chinese Society of Cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis. Sci China Life Sci. 2019; 62 (2): 187-202. https://doi.org/10.1007/ s11427-018-9385-3.

  44. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC [published correction appears in Eur Heart J. 2016 Dec 30]. Eur Heart J. 2016; 37 (27): 2129-2200. doi: 10.1093/eurheartj/ehw128.

  45. https://www.youtube.com/watch?v=l0_LAsOQExw




2020     |     www.medigraphic.com